amsterdam : DSM

April 28, 2011 12:33 ET

Final dividend Royal DSM N.V.

HEERLEN, NETHERLANDS--(Marketwire - Apr 28, 2011) - The DSM Annual General Meeting of Shareholders on 28 April 2011 passed a resolution to declare a dividend for 2010 of EUR 1.35 per ordinary share of EUR 1.50 par value. An interim dividend of EUR 0.40 per ordinary share having been paid on 27 August 2010, the final dividend for 2010 will amount to EUR 0.95 per ordinary share.

This final dividend of EUR 0.95 will be paid out in cash or in the form of ordinary shares at the option of the shareholder. Dividend in cash will be paid after deduction of 15% Dutch dividend withholding tax. The ex-dividend date on NYSE Euronext will be 2 May 2011 and the record date will be 4 May 2011.

Shareholders have from 5 May until 20 May 2011 (3.00 pm CET) to indicate their choice. On 20 May 2011 after the close of trading on NYSE Euronext the number of dividend rights of ordinary shares entitling the holder to one ordinary share will be determined.

This exchange ratio will be based on the volume weighted average price of all ordinary shares in DSM traded at NYSE Euronext on 16, 17, 18, 19 and 20 May 2011. The value of the stock dividend will be virtually equal to the value of the cash dividend. The ordinary shares that constitute the stock dividend are entitled to any dividend for the financial year 2011 and to the dividends for subsequent financial years. Stock dividend rights will not be traded on NYSE Euronext.

The following timetable applies:

2 May 2011:                              Ex-dividend quotation
4 May 2011:                              Record Date
5 May 2011 - 20 May 2011(3.00 pm CET):   Period in which shareholders can
                                         indicate their choice
23 May 2011 (COB):                       Announcement of the exchange ratio
25 May 2011:                             Delivery of shares or cash payment

DSM - Bright Science. Brighter Living.™

Royal DSM N.V. is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM's 22,000 employees deliver annual net sales of about EUR 9 billion. The company is listed on NYSE Euronext. More information can be found at www.dsm.com

Press release-pdf: http://hugin.info/130663/R/1510441/445471.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: DSM N.V. via Thomson Reuters ONE


Contact Information

  • For more information:
    DSM Corporate Communications
    Herman Betten
    tel. +31 (0) 45 5782017
    fax +31 (0) 45 5740680
    e-mail Email Contact

    DSM Investor Relations
    Hans Vossen
    tel. +31 (0) 45 5782864
    fax +31 (0) 10 4590275
    e-mail Email Contact